abstract |
The present invention relates to a pharmaceutical composition for preventing or treating obesity, containing cyclo(His-Pro) as an active ingredient. Specifically, the present invention has effects of reducing body weight and body mass and, further, improving leptin resistance. In addition, the present invention relates to a pharmaceutical composition for preventing or treating obesity, containing cyclo(His-Pro) and zinc and being administered once daily. |